SBI Holdings, Inc. and the Health Science Laboratory at Keio Research Institute at SFC, Keio University Establish the "Keio SBI ALA Laboratory"

December 1, 2017

We are pleased to announce that SBI Holdings, Inc. (Head office: Minato-ku, Tokyo; President and CEO: Yoshitaka Kitao; hereinafter "SBI Holdings") and the Keio Research Institute at SFC, Keio University (Location: Fujisawa City, Kanagawa Prefecture; Director: Hiroya Tanaka) have established the "Keio SBI ALA Laboratory" within the Innovation Center of NanoMedicine (iCONM), a research hub for advanced medical care operated by the Kawasaki Institute of Industrial Promotion, to conduct joint research on the ameliorating effects of 5-aminolevulinic acid (ALA) on age-related diseases.

[Laboratory Overview]

Name

:

Keio SBI ALA Laboratory

Date of establishment

:

December 1, 2017

Location

:

Inside the Innovation Center of NanoMedicine (iCONM) (Kawasaki City, Kanagawa Prefecture)

Research project title

:

"Promotion of Anti-Aging Medical Research Using Aminolevulinic Acid (ALA)"

For details, please see SBI Holdings, Inc. and the Health Science Laboratory at Keio Research Institute at SFC, Keio University Establish the "Keio SBI ALA Laboratory".pdf .

[Contact for this press release]

SBI Holdings, Inc.

Corporate Communications Department

TEL:

03-6229-0126

[Distributed by]

Academic Research Support, Shonan Fujisawa Campus (SFC) Office, Keio University